Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2331 (LINC02331)
- Target
- LINC02331
- Molecular classification
- Long non-coding RNA (lncRNA), Intergenic non-coding RNA
01
Overview
Long intergenic non-protein coding RNA 2331 (LINC02331) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-protein coding RNA[1]. LINC02331 does not overlap any protein-coding gene and its transcript is longer than 200 nucleotides. The biological function of LINC02331 itself has not been experimentally defined, which is typical for many lincRNAs[1][3]. In general, lincRNAs are thought to have roles in gene regulation at multiple levels and may act in cis (nearby) or trans (distant from their gene locus), but the specific cellular processes involving LINC02331 are not established[3]. There is no evidence that LINC02331 is currently considered a therapeutic drug target, receptor, enzyme, or similar class, nor are there reports of drug interactions, mechanism of action, or biomarker use for this RNA[1][3].
- Other names
- LINC02331long intergenic non-protein coding RNA 2331
02
Biological functions
Likely involved in gene regulationCould participate in chromatin modification, transcriptional regulation, or post-transcriptional regulation (based on lincRNA family functions, though not described specifically for LINC02331)
03
Disease associations
Not directly reported for LINC02331, but members of the lincRNA gene family have been implicated in cancer and complex human diseases (e.g., other lincRNAs such as Xist, TUNA), suggesting possible relevance
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2331 (LINC02331).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2331 (LINC02331).